Carisma Therapeutics

Ticker CARM

Exchange NYSE More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in Philadelphia, Pennsylvania

Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy. Their technology leverages advances in macrophage biology, chimeric antigen receptor engineering and adoptive cellular therapy for the treatment of human disease.

Visit website

REPORT RATINGS

3.8 / 5.0 (5)

Carisma Therapeutics reports have an aggregate usefulness score of 3.8 based on 5 reviews.

Carisma Therapeutics